نتائج البحث - "Anne, Uyei"

المصدر: Journal of Translational Medicine, Vol 15, Iss 1, Pp 1-9 (2017)
Journal of Translational Medicine
Journal of translational medicine, vol 15, iss 1

مصطلحات موضوعية: Male, Indoles, Skin Neoplasms, Time Factors, Photophobia, lcsh:Medicine, Eye, Medical and Health Sciences, Serous retinopathy, chemistry.chemical_compound, 0302 clinical medicine, Piperidines, Recurrence, Cobimetinib, Vemurafenib, Melanoma, Cancer, Sulfonamides, General Medicine, Middle Aged, Serous fluid, Central Serous Chorioretinopathy, 030220 oncology & carcinogenesis, MEK inhibition, Female, medicine.symptom, medicine.drug, Retinopathy, Adult, Proto-Oncogene Proteins B-raf, medicine.medical_specialty, Clinical Trials and Supportive Activities, Immunology, Asymptomatic, General Biochemistry, Genetics and Molecular Biology, 03 medical and health sciences, Blurred vision, Clinical Research, medicine, Humans, Visual disturbance, Eye Disease and Disorders of Vision, Aged, business.industry, Research, lcsh:R, medicine.disease, Dermatology, chemistry, Mutation, 030221 ophthalmology & optometry, Azetidines, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::730aff9f0d1b8da43fd76fb4a2c6989eTest
http://link.springer.com/article/10.1186/s12967-017-1246-0Test

9

Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial

المؤلفون: S Mullamitha, P Potemski, JB Ahn, Gavin Marx, David Cunningham, CG Ponce, James A. Jr Reeves, Cathy Eng, J Cultrera, Rachel Kerr, Neil H. Segal, Josep Tabernero, Marwan Fakih, J-L Canon, Salvatore Siena, JO Streb, YJ Cha, A Smolin, Javier Sastre Valera, S Begbie, Anne Uyei, Alberto Sobrero, Andrew Strickland, S Dowden, Ruth Vera Garcia, N Segal, AS Lee, Evaristo Maiello, E Chmielowska, S Badarinath, Niall C. Tebbutt, Tae Won Kim, K King, J Lee, B Lesperance, Ko Lam, M Van den Eynde, Vinod Ganju, B Tan, R. Young, K Chang, Brigette B.Y. Ma, Mark Kozloff, TY Kim, M Dvorkin, Maria Di Bartolomeo, Jo Park, Nick Pavlakis, M Kozloff, Philippe Vergauwe, Yibing Yan, E. Van Cutsem, M Wroblewska, M Womack, Michael M Vickers, Fortunato Ciardiello, Alfredo Falcone, A Chaudhry, Gabriele Luppi, J Kortmansky, Johanna C. Bendell, Ilsung Chang, John Marshall, RG Carbone, PJ Cuyle, R Mandanas, M Nechaeva, Félix Couture, Andrés Cervantes, Guillem Argiles, Scott M. Berry, Sherif Raouf, E Szutowicz-Zielinska, D Chu, SH Cho, John Davies, J. Asselah, S Baijal, Louise Roberts

المساهمون: Eng, Cathy, Kim, Tae Won, Bendell, Johanna, Argilés, Guillem, Tebbutt, Niall C, Di Bartolomeo, Maria, Falcone, Alfredo, Fakih, Marwan, Kozloff, Mark, Segal, Neil H, Sobrero, Alberto, Yan, Yibing, Chang, Ilsung, Uyei, Anne, Roberts, Louise, Ciardiello, Fortunato, UCL - SSS/IREC/MIRO - Pôle d'imagerie moléculaire, radiothérapie et oncologie, UCL - (SLuc) Service d'hépato-gastro-entérologie, UCL - (SLuc) Service d'oncologie médicale

المصدر: The Lancet Oncology, Vol. 20, no.6, p. 849-861 (2019)

مصطلحات موضوعية: Male, 0301 basic medicine, medicine.medical_specialty, Pyridines, Perforation (oil well), Phases of clinical research, Salvage therapy, Antibodies, Monoclonal, Humanized, Gastroenterology, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Piperidines, Atezolizumab, Internal medicine, Regorafenib, Antineoplastic Combined Chemotherapy Protocols, medicine, Clinical endpoint, Humans, Survival rate, Aged, Salvage Therapy, Cobimetinib, business.industry, Phenylurea Compounds, Liver Neoplasms, Middle Aged, Prognosis, Survival Rate, Editorial Commentary, 030104 developmental biology, chemistry, Oncology, 030220 oncology & carcinogenesis, Azetidines, Female, Colorectal Neoplasms, business, Follow-Up Studies

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::431ac9bf6155e274cf8d14cf254ce7bdTest
http://hdl.handle.net/11591/406353Test

10

Abstract CT012: Evaluation of atezolizumab (A), cobimetinib (C), and vemurafenib (V) in previously untreated patients with BRAFV600 mutation-positive advanced melanoma: Primary results from the phase 3 IMspire150 trial

المؤلفون: Caroline Robert, Kuan Chieh Huang, Thomas Eigentler, Piotr Rutkowski, Grant A. McArthur, Rodrigo Perez Pereira, Daniil Stroyakovskiy, Georgy M. Manikhas, Svetlana Protsenko, Anne Uyei, Karl D. Lewis, Helen Gogas, Lev V. Demidov, Yibing Yan, Paolo A. Ascierto, Ralf Gutzmer, Virgina McNally

المصدر: Cancer Research. 80:CT012-CT012

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::a2a2703c0fb7cb5acf4424a878d960baTest
https://doi.org/10.1158/1538-7445.am2020-ct012Test

تنقيح النتائج